Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2449022 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL26953 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL301131 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL14675991 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL3175920 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL9634079 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL5511391 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL9633702 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL22157999 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM | |
| SCHEMBL3184929 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLGAAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0212991-B1 | IMPROVED RHODIUM CATALYZED HYDROFORMYLATION OF ALPHA-SUBSTITUTED ALPHA-OLEFINS | EXXON CHEMICAL PATENTS INC. (US) | 1992-05-27 | — | — | EP | claimed |
| US-4642388-A | TRICYLLOALKYL PHOSPHINE LIGANDS, HIGH SELECTIVITY | EXXON CHEMICAL PATENTS INC. (US) | 1987-02-10 | — | — | US | claimed |
| US-4625068-A | STERICALLY HINDERED PHOSPHINE LIGNANDS; CATALYSTS | EXXON CHEMICAL PATENTS INC. (US) | 1986-11-25 | — | — | US | claimed |
| US-20260035328-A1 | CYCLIC DIENE-CONTAINING COMPOSITION, PRODUCTION METHOD FOR ALDEHYDE, PRODUCTION METHOD FOR ALCOHOL, AND PRODUCTION METHOD FOR CYCLIC DIENE-CONTAINING COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-02-05 | — | — | US | disclosed |
| US-20250304516-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, ULTRAVIOLET-CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANEDIMETHANOL COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4617255-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD | Mitsubishi Chemical Corporation (JP) | 2025-09-17 | — | — | EP | disclosed |
| WO-2025057968-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD | 三菱ケミカル株式会社 | 2025-03-20 | — | — | WO | disclosed |
| CN-118765270-B | Tricyclodecane dimethanol composition, ultraviolet curable composition, polymer composition, and process for producing tricyclodecane dimethanol composition | 三菱化学株式会社 | 2025-03-07 | — | — | CN | disclosed |
| US-20250026703-A1 | TRICYCLODECANE DIMETHANOL COMPOSITION, ULTRAVIOLET CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANE DIMETHANOL COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-01-23 | — | — | US | disclosed |
| EP-4495096-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD | Mitsubishi Chemical Corporation (JP) | 2025-01-22 | — | — | EP | disclosed |
| EP-4467530-A1 | PRODUCTION METHOD FOR POLYALCOHOL | Mitsubishi Chemical Corporation (JP) | 2024-11-27 | — | — | EP | disclosed |
| US-6175047-B1 | A CATALYST MIXTURE INCLUDING A RUTHENIUM COMPOUND, A DIHALOGENO COMPOUND, A TERMINAL ALKYNE; AS A CATALYST FOR A CARBON-CARBON BOND FORMATION REACTION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-1065194-A1 | Production of tricyclodecane dicarbaldehyde, pentacyclopentadecane dicarbaldehyde and corresponding dimethanols | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-01-03 | — | — | EP | disclosed |
| EP-0927577-A1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | Takasago International Corporation (JP) | 1999-07-07 | — | — | EP | disclosed |
| EP-0212991-B1 | IMPROVED RHODIUM CATALYZED HYDROFORMYLATION OF ALPHA-SUBSTITUTED ALPHA-OLEFINS | EXXON CHEMICAL PATENTS INC. (US) | 1992-05-27 | — | — | EP | disclosed |
| EP-0195656-B1 | IMPROVED RHODIUM CATALYZED HYDROFORMYLATION OF INTERNAL OLEFINS | EXXON CHEMICAL PATENTS INC. (US) | 1990-09-26 | — | — | EP | disclosed |
| EP-0212991-A1 | Improved rhodium catalyzed hydroformylation of alpha-substituted alpha-olefins | EXXON CHEMICAL PATENTS INC. (US) | 1987-03-04 | — | — | EP | disclosed |
| US-4642388-A | TRICYLLOALKYL PHOSPHINE LIGANDS, HIGH SELECTIVITY | EXXON CHEMICAL PATENTS INC. (US) | 1987-02-10 | — | — | US | disclosed |
| US-4625068-A | STERICALLY HINDERED PHOSPHINE LIGNANDS; CATALYSTS | EXXON CHEMICAL PATENTS INC. (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0195656-A1 | Improved rhodium catalyzed hydroformylation of internal olefins | EXXON CHEMICAL PATENTS INC. (US) | 1986-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035328-A1 | CYCLIC DIENE-CONTAINING COMPOSITION, PRODUCTION METHOD FOR ALDEHYDE, PRODUCTION METHOD FOR ALCOHOL, AND PRODUCTION METHOD FOR CYCLIC DIENE-CONTAINING COMPOSITION | ADH1C, ADH1A, ADH5 | ALDH1A1 4/4885HSD17B10 12/4885MGLL 1483/4885 |
| US-20250304516-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, ULTRAVIOLET-CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANEDIMETHANOL COMPOSITION | XPA, XPOT, ACMSD | ALDH1A1 3860/4885HSD17B10 1877/4885MGLL 3561/4885 |
| US-20250026703-A1 | TRICYCLODECANE DIMETHANOL COMPOSITION, ULTRAVIOLET CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANE DIMETHANOL COMPOSITION | ERCC5, ERCC1, XPA | ALDH1A1 3491/4885HSD17B10 1133/4885MGLL 1809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.